Alnylam Pharmaceuticals
ALNY
#555
Rank
HK$331.42 B
Marketcap
HK$2,499
Share price
-3.01%
Change (1 day)
20.41%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company